Biogen’s anti-tau Alzheimer’s drug misses Phase 2 goal, but claims signs of efficacy

Trending

• Uncategorized9 years ago

  These ’90s fashion trends are making a comeback in 2017

• Uncategorized9 years ago

  According to Dior Couture, this taboo fashion accessory is back

• Endpoints News3 months ago

  Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation

• Uncategorized9 years ago

  Phillies’ Aaron Altherr makes mind-boggling barehanded play

• Uncategorized9 years ago

  Uber and Lyft are finally available in all of New York State

• Contributors9 years ago

  The final 6 ‘Game of Thrones’ episodes might feel like a full season